awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33401272-66BDE865-154B-4D24-83D4-B950AB591020
Q33401272-66BDE865-154B-4D24-83D4-B950AB591020
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33401272-66BDE865-154B-4D24-83D4-B950AB591020
Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial.
P2860
Q33401272-66BDE865-154B-4D24-83D4-B950AB591020
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33401272-66BDE865-154B-4D24-83D4-B950AB591020
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
86eb8d7d62489b764444838992b4aba5ea735b75
P2860
c-Met expression is regulated by Mitf in the melanocyte lineage.